secwatch.observer — SEC 8-K summary
======================================

Issuer:     Incannex Healthcare Inc. (IXHL)
CIK:        0001873875
Form:       8-K
Filed at:   2026-03-12T23:59:59+00:00
Accession:  0001213900-26-026645
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Incannex Healthcare announces $10M registered direct offering of 2M shares and warrants at $5.00/unit
--------------------------------------------------------------------------------

- Offering consists of 2,000,000 shares (or equivalents) and 2,000,000 common warrants; combined price $5.00 per share and accompanying warrant.
- Gross proceeds ~$10M; warrants exercisable at $6.50 for 5 years; potential additional $13M if fully exercised.
- Proceeds expected to fund Phase 2 DReAMzz study for IHL-42X; prior cash on hand reserved for Phase 3 anticipated in H2 2027.
- Company terminated its at-the-market facility and does not intend to use ATM near term.
- Offering expected to close March 13, 2026; Curvature Securities acted as sole placement agent.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1873875/000121390026026645/0001213900-26-026645-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1873875/000121390026026645/ea0278296-8k_incannex.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-026645

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer